Insider Transactions
| Date | Name | Title | Type | Filing | Shares Traded | Price Range | Total Held |
|---|---|---|---|---|---|---|---|
| Aug 27, 2014 | Director | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Form 4 | 10,000 | -- | -- | |
| Aug 20, 2014 | VP, Technical Operations | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Form 4 | 5,000 | -- | -- | |
| Jun 27, 2014 | Director, Chairman & CEO | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Form 4 | 16,491 | -- | -- | |
| Dec 03, 2013 | Vice President Clinical Ops | Initial Statement of Beneficial Ownership of Securities | Form 3 | -- | -- | -- | |
| Dec 03, 2013 | Vice President Clinical Ops | Initial Statement of Beneficial Ownership of Securities | Form 3 | -- | -- | -- | |
| Dec 03, 2013 | Vice President Clinical Ops | Initial Statement of Beneficial Ownership of Securities | Form 3 | -- | -- | -- | |
| Dec 03, 2013 | Vice President Clinical Ops | Initial Statement of Beneficial Ownership of Securities | Form 3 | -- | -- | -- | |
| Feb 11, 2013 | VP, Program Management | Initial Statement of Beneficial Ownership of Securities | Form 3 | -- | -- | -- | |
| Feb 11, 2013 | VP, Program Management | Initial Statement of Beneficial Ownership of Securities | Form 3 | -- | -- | -- | |
| Feb 11, 2013 | VP, Program Management | Initial Statement of Beneficial Ownership of Securities | Form 3 | -- | -- | -- |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.